This disclosure sets forth bubble modifiers capable of reducing mean bubble diameter of a gasified aqueous solution, e.g., a carbonated beverage. The bubble modifier may include one or more compounds selected from the group consisting of monocaffeoylquinic acids, dicaffeoylquinic acids, monoferuloylquinic acids, diferuloylquinic acids, monocoumaroylquinic acids, dicoumaroylquinic acids, and salts thereof. The bubble modifier desirably comprises less than 0.3% (wt) of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid; or less than 0.05% (wt) of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate, or acetic acid; or less than about 0.05% (wt) of chlorophyll; or less than about 0.1% (wt) of furans, furan-containing chemicals, theobromine, theophylline, or trigonelline.

[Problem] To provide a novel technique with which it is possible to reduce acetic acid irritation and difficulty to drink derived from acetic acid which may be sensed during drinking of an acetic acid-containing beverage.

[Solution] This beverage contains acetic acid in an amount of 10-800 ppm and gluconic acid in an amount of 50-2000 ppm, and has an acidity due to citric acid of 0.1-0.4 g/100 ml.

[Selected Drawing] None

[Problem] To provide a novel technique with which it is possible to reduce acetic acid irritation and difficulty to drink derived from acetic acid which may be sensed during drinking of an acetic acid-containing beverage.

[Solution] This beverage contains acetic acid in an amount of 10-800 ppm and gluconic acid in an amount of 50-2000 ppm, and has an acidity due to citric acid of 0.1-0.4 g/100 ml.

[Selected Drawing] None

Provided is a method of producing a liquid mineral extract containing an abundant amount of potassium that is a mineral component extremely important for humans. A mineral is extracted from activated carbon of a plant-derived raw material using an aqueous solvent.

Provided is a method of producing a liquid mineral extract containing an abundant amount of potassium that is a mineral component extremely important for humans. A mineral is extracted from activated carbon of a plant-derived raw material using an aqueous solvent.

The disclosed subject matter provides preservative-free liquid flavored beverage concentrate compositions, food package kits comprising such compositions, and methods of preparing such compositions and kits.

The disclosed subject matter provides preservative-free liquid flavored beverage concentrate compositions, food package kits comprising such compositions, and methods of preparing such compositions and kits.

A formulation for providing hydration and nutritional components to a subject includes from about 1,000 mg/serving to about 7,000 mg/serving of trimethylglycine, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable precursor thereof; from about 1 mg/serving to about 4,000 mg/serving of beta-hydroxybutyric acid or a pharmaceutically acceptable salt thereof; an electrolyte salt; optionally a purine nucleotide; and optionally a carbohydrate. The formulation may be an orally administered liquid including an aqueous carrier in an amount sufficient to provide a total volume/serving of about 2 oz. to about 32 oz.

A formulation for providing hydration and nutritional components to a subject includes from about 1,000 mg/serving to about 7,000 mg/serving of trimethylglycine, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable precursor thereof; from about 1 mg/serving to about 4,000 mg/serving of beta-hydroxybutyric acid or a pharmaceutically acceptable salt thereof; an electrolyte salt; optionally a purine nucleotide; and optionally a carbohydrate. The formulation may be an orally administered liquid including an aqueous carrier in an amount sufficient to provide a total volume/serving of about 2 oz. to about 32 oz.

The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (−)-gallocatechin gallate (GCG) and (−)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.